期刊文献+

雄黄抑制宫颈癌细胞株增殖和诱导凋亡的体外研究 被引量:2

The Study of Cervical Cancer Hela Cell inhibition and Apoptosis Induced by As4S4
下载PDF
导出
摘要 目的:体外研究中药雄黄主要成分As4S4对子宫颈癌细胞株Hela细胞的增殖抑制和诱导凋亡的作用。方法:以As4S4不同浓度(7.5、15、30、60mg/L),分12h,24h,36h,48h,60h处理Hela细胞,用光镜观察细胞变化;四甲基偶氮唑蓝(MTT)法测定细胞增殖抑制率;流式细胞仪(FCM)检测细胞凋亡率;用DNA梯状电泳(DNA ladder)检测凋亡的发生。结果:不同浓度(7.5、15、306、0 mg/L)的As4S4处理的Hela细胞,细胞增殖受到抑制,作用呈明显的时效和量效关系,差异有非常显著性(P<0.01);As4S4诱导Hela细胞的凋亡率为(8.13±1.13)%^(62.36±4.42)%,与对照组比较(2.84±1.88)%,差异有极显著性(P<0.01),并呈浓度依赖性;DNA ladder呈梯状条带。结论:雄黄体外对宫颈癌细胞株Hela细胞具有增殖抑制和促进凋亡作用。 Objective: To investigate the Cervical cancer Hela cells growth inhibition and apoptosis induced by Tetra-arsenic tetra-sulfide (As4S4). Methods: Hela cells were treated with As4S4 in various concentrations(7.5.15.30.60 mg/L)at different hours( 12h, 24h, 36h, 48h, 60h). Cell growth was measured by MTT. Apoptosis was detected by double staining flowcytometry (FCM) and DNA Ladder. Results: After treated with different concentrations of As4S4(7. 5, 15, 30, 60 mg/L ), the cell growth of Hela was suppressed significantly with showed dose-and time-dependent manner increase in proliferative inhibition rate(P d0.01). FCM analysis showed the As4S4 can induce apoptosis (8.13±1.13)% -(62.36 ±4.42)% significantly with showed dose-and time-dependent manner, compared with control group(2.84±1.88)% , (P〈 0. 01); DNA fragmentation gel analysis showed DNA ladder. Conclusion: As4S4 could inhibit the proliferation and increase apoptosis in human Hela cells.
出处 《数理医药学杂志》 2007年第6期785-787,共3页 Journal of Mathematical Medicine
关键词 AS4S4 增殖抑制 HELA细胞 凋亡 As4S4 hela cell apoptosis ihibition
  • 相关文献

参考文献10

二级参考文献21

  • 1张晨,黄世林,向阳,马东初,孙英慧,马小峰.低剂量雄黄诱导NB_4细胞凋亡的研究[J].中国中医基础医学杂志,2000,6(2):11-13. 被引量:34
  • 2黄世林,郭爱霞,向阳,王晓波,林慧娴,富丽.复方青黛片为主治疗急性早幼粒细胞白血病的临床研究[J].中华血液学杂志,1995,16(1):26-28. 被引量:185
  • 3粟俭.药物诱导的肿瘤细胞凋亡研究进展[J].国外医学(肿瘤学分册),1995,22(1):7-10. 被引量:59
  • 4周霭祥 姚宝森 等.青黄散治疗慢性粒细胞白血病25例近期疗效观察[J].中西医结合杂志,1981,1(1):16-16.
  • 5Kamitani T, Kito K, Nguyen HP, et al. Identification of three major sentrinization sites in PML. J Biol Chem,1998; 273:26675 - 26682
  • 6Gambacorta M, Flenghi L, Fagioli M, et al. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am J Pathol, 1996; 149:2023- 2035
  • 7Cao T, Duprez E, Borden K, et al. Ret finger protein is a normal component of PML nuclear bodies and interacts directlywith PML. J Cell Sci, 1998; 111(pt 10):13191329
  • 8Everett RD, Maul GG. HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J, 1994; 13:5062 - 5069
  • 9Zhu J, Koken MH, Quignon F, et al. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc Natl Acad Sci USA, 1997; 94:3978 - 3983
  • 10孔凡盛,蔡新吉,迟翠芳,黄世林.复方青黛片治疗复发性急性早幼粒细胞白血病疗效观察[J].临床血液学杂志,1997,10(3):103-104. 被引量:7

共引文献155

同被引文献10

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部